Lecture 10 - Hemostasis Part 2 Flashcards

1
Q

Secondary hemostasis: the main goal is to produce a VERY stable ______ _____ and
the way to do it is binding ______ to the _______ _____ formed during the primary
hemostasis). Remember that for Hemostasis (or clot formation) to occur the initiating step is to have= vascular ______. The parallel activation of _______ and coagulation system occurs at sites of vascular ______.

A

Secondary hemostasis: the main goal is to produce a VERY stable platelet plug and
the way to do it is binding FIBRIN to the platelet plug (formed during the primary
hemostasis). Remember that for Hemostasis (or clot formation) to occur the initiating
step is to have= vascular injury. The parallel activation of platelets and coagulation
system occurs at sites of vascular injury.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The process of coagulation is dependent upon:
1. Coagulation factors
* Synthesized in the _____
* _______ and ____-______ factors
2. Cells (4)

A
  1. Coagulation factors
    * Synthesized in the liver
    * Enzymatic and non-enzymatic factors
  2. Cells
    * Fibroblasts
    * Platelets
    * Endothelial cells
    * Leukocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List the enzymatic factors required for the coagulation cascade.

A

1, 1a, 2, 2s, 7a, 9a, 10a, 11a, 12a
9a = christmas factor
7a = proconvertin
10a = stuart factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List the non-enzymatic factors required for the coagulation cascade.

A

5a, 8a, Factor 3/Thromboplastin/Tissue factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List the Vitamin-K dependent coagulation factors.
Which of these factors has the shortest half life?

A

For activation dependent on Vitamin K
* Factors II, VII, IX, X
* Factor VII (shortest half-life)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Vitamin K is needed for production of activated coagulant Factors ___, ___, ___, ___
(and ?) –remember most clotting factors
are produced in the ______ (by _____).
So if the patient has ______ disease or failure, you will see a decreased production of clotting factors due to progressive loss of _________ (coagulation tests can be indirect tests of _____ function).

A

2, 7, 9 10
anticoagulant Prot. C & S
LIVER
hepatocytes

hepatocytes
liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Inactive precursors (__________) are made functional by Vit. ___-dependent ___ translational _______ of _______ acid residues on the molecules. This process is facilitated by the Vitamin ___ epoxide reductase enzyme. _______ inhibit this enzyme.

A

procoagulants, K, post, carboxylation, Glutamine
K
Coumarins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

An increase in clotting factors remaining in their inactive state is caused by?

A

Vitamin K Antagonism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What causes Vitamin K Antagonism?

A
  1. Coumarin-containing compounds: rodenticides, warfarin, moldy sweet clover
  2. Fat malabsorption: cannot absorb fat soluble Vit. K
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tissue factor/Thromboplastin starts the ______ cascade after injury.

A

extrinsic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Coagulation factor IV (4) is called ______ and is needed for the coagulation cascade enzymatic factors to work.

A

Calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Coagulation factor X is called _______ ______ factor and starts the common pathway + cleaves coagulation factor II.

A

Stuart-Prower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Coagulation factor XII is called the ______ factor and plays a minor role in fibrinolysis.

A

Hageman

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The extrinsic pathway is INITIATED by _______ tissue/cells who consequently release ______ factor which is expressed on ________ at site of vascular injury to activate the ________ path. By expression of this factor, Factor ____ is activated. Then factor ____ in the presence of ____, ____, activates factor _____ to factor ____ to Begin
common pathway. This generates small amounts of _______.

THIS IS THE FIRST STEP of _______ Hemostasis: initiation of ______ generation
____ Factor + ___ = => formation of Factor ___ activation complex.

A

damaged, Tissue, Fibroblasts, EXTRINSIC, 7, VIIa, TF, Ca2++, F10, 10a, Thrombin, Secondary, Thrombin, Tissue, 7, 10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The intrinsic pathway begins when Factor ____ is exposed to collagen or other negatively charged substances (3?), activating Factor ___ –> ____.
Now Factor ___ activates Factor ___ into Factor ___. With a _______ Ion, Factor _____ activates Factor ___.
Now Factors ___ and ____, along with _______, form a complex to activate Factor ___. The end

A

The intrinsic pathway begins when F12 is exposed to collagen or other negatively
charge substances (like PLT, phosphates, endotoxins), activating F12. The F12a is activated
Now F12a activates F11 into F11a. With a Calcium Ion, F11a activates F9
Now F9a, F8a and Ca2+ form a complex to activate F10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Note: Factor IX can also be activated by the ?

A

TF-VIIa complex (cross- over from extrinsic pathway)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

F8 is found in the _____ and is often activated by ?

A

blood, Thrombin (FIIa)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Factor VIII
* Usually circulates as a ___-_______ complex with ______
* The _____ bound to F8 does not participate in the _______ pathway of coagulation
* Functions in hemostasis by promoting
platelet _____ and ______

A

non-covalent, vWF, vWF, Intrinsic, adhesion, aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

The common pathway begins with the activation of factor 10 via _______ or _____ pathways. Now Factor 10a, along with ______, activates Factor ___ to ___.
Now activated ____, _____ bind with Ca to form a complex that promotes activation of
__________ to activated _______. Then, Factor _____ cleaves Fibrinogen (F1) into ______. The last and final step is?

A

Intrinsic, extrinsic
Now 10a together with Thrombin (2a) from extrinsic pathway activates 5 to 5a

Now activated 10a, 5a bind with Ca to form a complex that promotes activation of
Prothrombin (F2) to activated F2a=thrombin

Now thrombin (F2a) cleaves Fibrinogen (F1) into fibrin (F1a).

F13a (needs Calcium and this cross-links w fibrin strands of the soft clot to form a
hard clot.
The common pathway is the last and final step of the secondary hemostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

At the same time as the coagulation cascade, the fibrinolytic system is operating.
Fibrin, Factor 1a, is degraded in fibrin _________ products by ______ that originates from fibrin bound _______ in liver.
Removal of fibrin clots is necessary for wound ______ and reestablishment of ______,
also prevents ______.

A

degradation
PLASMIN, plasminogen, healing, circulation, thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

As a stable fibrin clot is formed then thrombin production ________ and _______ dominates

A

decreases, fibrinolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

The fibrin clot is removed by the proteolytic action of ______, which comes from its precursor: ________ (produced in ____
and circulates in _____).

A

plasmin, Plasminogen, liver, plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Plasminogen is activated by ______ ________ activator which comes from local ______ cells.

A

tissue
plasminogen
endothelial

25
Q

Small amounts of plasminogen may be activated by ?

A

F12a and F11a, and Thrombin (F2a)

26
Q

Increases in FPDs & D-Dimers indicates ?

A

increased Intravascular coagulation with clot breakdown

27
Q

The tissue factor inhibitor inhibits?

A

the TF-F7a complex

28
Q

Anti-thrombin III inactivates ________ as well as _____, _____, and ____.

A

Thrombin, F9a, 10a, 11a

29
Q

Tissue plasminogen activator (tPA) cleaves _______ –> ______

A

plasminogen, plasmin

30
Q

Deficiencies in which substances increase the risk of thrombosis?

A
  1. Antithrombin (AT)
  2. Thrombomodulin (TM)
  3. Protein C
  4. Tissue factor pathway inhibitor (TFPI)

Each of theses substances inhibit coagulation, so deficiency = risk of thrombosis

31
Q

Antithrombin is
* Produced in ______
* Accounts for ~ ____% of total ____________ activity in plasma
* Inhibits primarily: Factor ___ and ________
* ________ increases ________ activity by ~1,000x
* Acquired AT deficiencies can occur due to:
1. Increased __________ (DIC)
2 Increased loss (protein ______ nephropathy)
3. Decreased production (in _____ dz) –rare-

A

Antithrombin is
* Produced in liver
* Accounts for ~ 70% of total anticoagulant activity in plasma
* Inhibits primarily: Factor Xa and Thrombin
* Heparin increases AntiThrombin activity by ~1,000x
* Acquired AT deficiencies can occur due to:
* Increased consumption (DIC)
* Increased loss (protein losing nephropathy)
* Decreased production (in liver dz) –rare-

32
Q

Thrombomodulin is
* Produced by ________ cells
* Binds to ________ and decreases the its ability to form _____

A
  • Produced by endothelial cells
  • Binds to thrombin and decreases the thrombin ability to form clots
33
Q

Protein C
* Produced in ______
* Activated by ________/_________ complex
* Inactivates factors _____ and ____
* Increases ________ by facilitating activation of ______

A
  • Produced in Liver
  • Activated by Thrombomodulin/thrombin complex
  • Inactivates F5a and F8a
  • Increases fibrinolysis by facilitating activation of plasmin
34
Q

Tissue factor pathway inhibitor
* Forms a complex with ______ to inhibit the action of _____-___ complex
* Potent _____

A
  • Forms a complex with F7a to inhibit the action of F7a-TF complex
  • Potent inhibitor
35
Q

Name the factor that activate fibrinolysis.

A
  • Tissue factor plasminogen (tPA)
  • Factor XIa
  • Factor XIIa
36
Q

Name the factors that inhibit fibrinolysis.

A
  • Alpha2-antiplasmin
  • Plasminogen activator inhibitor
    (PAI)
  • Thrombin (F2a)
37
Q

Samples meant to be evaluated for hemostasis are put into a ____ colored top tube containing?

A

blue, 3.2% sodium citrate

38
Q

Citrated plasma does not contain?

A

RBCs, WBCs, or platelets.
Decreased Calcium (chelated by citrate)

39
Q

Name the procoagulant tests.

A
40
Q

Name the anticoagulant tests.

A
41
Q

Which tests evaluate the intrinsic pathway?

A

PTT or aPTT, ACT
Tip: your poker table tournaments are always inside, For the INTRINSIC Pathway

42
Q

Which tests evaluate the extrinsic pathway?

A

PT
Tip: you Park trucks outside for the Extrinsic pathway

43
Q

aPTT and ACT
* Measure time for _____ _____ formation
* Significance of prolonged time:
1. Deficiency or inhibitor of any _____
or ______ pathway factor
2. _____ therapy

A

fibrin clot
intrinsic, common, Heparin

44
Q

aPTT
* Measures time for fibrin clot formation in
* _______ plasma + contact ______ + _______ + ____ phospholipid substitute
* Requires ~___% deficiency of any factor before prolongation is detected
* More sensitive test than ____.

Prolonged PTT results indicate:
* Deficiency in ______ factors: ?
* Deficiency in _____ pathway factors
* Increased concentrations of _____ (example: ____ therapy)

A

citrated, activator, Calcium, PLT, 70, ACT

INTRINSIC, 12, 11. 9, 8, common, inhibitors, heparin

45
Q

ACT
* Measures time for fibrin clot formation in _____________ blood. It is Collected in specialized tube containing a ______ _____ where exogenous ____ phospholipids is not added.
oSevere ________ (<_____/uL) can cause slight
prolongation
* Requires ~____% deficiency of factor before prolongation is detected
* Inexpensive, simple test

A

non-anticoagulated, contact activator, PLT, thrombocytopenia, 10,000, 95

46
Q

PT
* Measures time for fibrin clot formation in: _________ plasma + ____ + _____ + ____ phospholipid substitute
§ Requires ~___% deficiency of factor before prolongation is detected

  • Significance of prolonged time
    1. Deficiency of Factor ____
    2. Good screening test for Vit. ___ deficiency because of the short t ½ life of ___
    3. Deficiency or inhibition of _____ pathway factors (?)
A

Citrated, TF, Calcium, PLT, 70, VII, K, F7, common, fibrinogen, thrombin, 5, 10

47
Q

Fibrinogen testing:
1. Heat precipitation method
* Typically performed to detect __________ due to _________ in large animals
* Not sensitive enough to detect ___________
2. Immunologic assays
* Determine _______ but not _______ of fibrinogen
3. Thrombin clotting time (TCT)/Thrombin time (TT)
* Indicates amount of ______ fibrinogen
* If prolonged can indicate:
- ____fibinogenemia
- ____fibrinogenemia (not properly function fibrinogen)
- Presence of fibrinogen _______
* Used when abnormal ____ or _____ results

A

hyperfibrinogenemia, inflammation, hypofibrinogenemia

amount, functionality

functional, Hypo, Dys, inhibitors

PT, PTT

48
Q

FDPs come from?

A

From Fibrinogen and soluble Fibrin by effects of Plasmin

49
Q

D-dimers come from?

A

From Cross linked fibrin by effects of Plasmin

50
Q

Latex tube agglutination test
* Uses latex beads coated w/ ________ directed against ____ or _______
* Agglutination occurs if ____ or ______ are present.
* Increased ____ or _______ indicate excessive fibrinolysis.

A

antibodies, FDPs, D-dimers, FDPs, D-dimers

FDPs, D-dimers

51
Q

Rarely, Increased FDPs alone, will be seen in
* large ______ bleeds (example: ________ or ________) due to increased breakdown of ________ and will have ______ D-dimers

A

cavitary, rodenticide, hemophilia, fibrinogen, normal

52
Q

Increased FDPs occur with?

A
  • Increased fibrinolysis
  • Severe internal hemorrhage with
    fibrinolysis
  • Decreased clearance of FDP by liver
53
Q

Increased D-dimers occurs with?

A
  • Increased fibrinolysis
  • Severe internal hemorrhage with
    fibrinolysis
  • DIC, thrombosis (animal in LATE DIC have
    consumed all their clotting factors )
  • Decreased clearance by liver
54
Q

D-dimers are more ________ and ______ than FDP quantification

A

sensitive, specific

55
Q

Antithrombin activity can be decreased because of?
* Decreased production in _____ failure
* Increased ____ (e.g. protein losing nephropathy)
* Increased _______ (e.g. DIC)
* Results reported as % activity compared to control

A

liver, loss, consumption

56
Q

Coagulopathies
* _______ or ________
* May be combined with disorders of ______ hemostasis (platelet
disorders)
* Pattern of hemorrhage as clinical signs
* Major hemorrhages, often in _____ sites
* ________, _______ hematomas,
* ________
* Bleeding into _______ (hemothorax, hemoabdomen), _____
* Blood in _____, or in _____ or in ____

A

Acquired, congenital, primary, multiple
Subcutaneous, Intramuscular, Ecchymosis, cavities, joints, stool, vomit, urine

57
Q

Causes of coagulopathies
* Most common occur due to _______ production of coagulation
factors
* Production of ______ molecules
* Increased _______ or ____ of factors
* Presence of circulating _________ or _______ directed against factors (very rare)

A

DECREASED, abnormal, consumption, loss,
inhibitors, antibodies

58
Q
  • Isolated deficiencies in certain factors can be _________ or cause ____ bleeding problems (may ____ easily) –> Factors __ & ___
  • Deficiencies in Factors __ & __ or ______ pathway factors cause more
    severe problems
A

asymptomatic, mild, bruise, 11, 12, 8, 9, common